Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Rediscovering Medicinal Amazonian Aromatic Plants: Piper carpunya (Piperaceae) Essential Oil as Paradigmatic Study.

Ballesteros JL, Tacchini M, Spagnoletti A, Grandini A, Paganetto G, Neri LM, Marengo A, Angiolella L, Guerrini A, Sacchetti G.

Evid Based Complement Alternat Med. 2019 Jan 1;2019:6194640. doi: 10.1155/2019/6194640. eCollection 2019.

2.

Chromatographic Analyses, In Vitro Biological Activities, and Cytotoxicity of Cannabis sativa L. Essential Oil: A Multidisciplinary Study.

Zengin G, Menghini L, Di Sotto A, Mancinelli R, Sisto F, Carradori S, Cesa S, Fraschetti C, Filippi A, Angiolella L, Locatelli M, Mannina L, Ingallina C, Puca V, D'Antonio M, Grande R.

Molecules. 2018 Dec 10;23(12). pii: E3266. doi: 10.3390/molecules23123266.

3.

Antioxidant, Antifungal, Antibiofilm, and Cytotoxic Activities of Mentha spp. Essential Oils.

Stringaro A, Colone M, Angiolella L.

Medicines (Basel). 2018 Oct 21;5(4). pii: E112. doi: 10.3390/medicines5040112. Review.

4.

Antimicrobial and Antioxidant Activities of Natural Compounds.

Angiolella L, Sacchetti G, Efferth T.

Evid Based Complement Alternat Med. 2018 Jun 6;2018:1945179. doi: 10.1155/2018/1945179. eCollection 2018. No abstract available.

5.

The socioeconomic burden of patients affected by hemophilia with inhibitors.

D'Angiolella LS, Cortesi PA, Rocino A, Coppola A, Hassan HJ, Giampaolo A, Solimeno LP, Lafranconi A, Micale M, Mangano S, Crotti G, Pagliarin F, Cesana G, Mantovani LG.

Eur J Haematol. 2018 Oct;101(4):435-456. doi: 10.1111/ejh.13108. Epub 2018 Jul 27. Review.

PMID:
29889317
6.

Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry.

Le Heuzey JY, Bassand JP, Berneau JB, Cozzolino P, D'Angiolella L, Doucet B, Mantovani LG, Martelet M, Mouallem J, Muller JJ, Pieper K; GARFIELD-AF Investigators.

Arch Cardiovasc Dis. 2018 Dec;111(12):749-757. doi: 10.1016/j.acvd.2018.03.012. Epub 2018 Jun 1.

PMID:
29861295
7.

Chemical characterization and antifungal activity of Origanum vulgare, Thymus vulgaris essential oils and carvacrol against Malassezia furfur.

Vinciguerra V, Rojas F, Tedesco V, Giusiano G, Angiolella L.

Nat Prod Res. 2018 May 4:1-5. doi: 10.1080/14786419.2018.1468325. [Epub ahead of print]

PMID:
29726703
8.

Costs and effectiveness of influenza vaccination: a systematic review.

D'Angiolella LS, Lafranconi A, Cortesi PA, Rota S, Cesana G, Mantovani LG.

Ann Ist Super Sanita. 2018 Jan-Mar;54(1):49-57. doi: 10.4415/ANN_18_01_10. Review.

9.

Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: A Systematic Literature Review.

D'Angiolella LS, Cortesi PA, Lafranconi A, Micale M, Mangano S, Cesana G, Mantovani LG.

Pharmacoeconomics. 2018 May;36(5):567-589. doi: 10.1007/s40273-018-0618-5. Review.

PMID:
29441473
10.

Modern Treatments of Haemophilia: Review of Cost-Effectiveness Analyses and Future Directions.

Cortesi PA, D'Angiolella LS, Lafranconi A, Micale M, Cesana G, Mantovani LG.

Pharmacoeconomics. 2018 Mar;36(3):263-284. doi: 10.1007/s40273-017-0588-z. Review.

PMID:
29170896
11.

Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context.

D'Angiolella LS, Cortesi PA, Pitotti C, Ritrovato D, Mantovani LG, Senni M.

Eur J Heart Fail. 2017 Nov;19(11):1551-1553. doi: 10.1002/ejhf.919. Epub 2017 Aug 28. No abstract available.

12.

Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment.

Cortesi PA, D'Angiolella LS, Vellucci R, Allegri M, Casale G, Favaretti C, Kheiraoui F, Cesana G, Mantovani LG.

PLoS One. 2017 Jun 27;12(6):e0179523. doi: 10.1371/journal.pone.0179523. eCollection 2017.

13.

Targeting Malassezia species for Novel Synthetic and Natural Antidandruff Agents.

Angiolella L, Carradori S, Maccallini C, Giusiano G, Supuran CT.

Curr Med Chem. 2017;24(22):2392-2412. doi: 10.2174/0929867324666170404110631. Review.

PMID:
28393697
14.

Biofilm, adherence, and hydrophobicity as virulence factors in Malassezia furfur.

Angiolella L, Leone C, Rojas F, Mussin J, de Los Angeles Sosa M, Giusiano G.

Med Mycol. 2018 Jan 1;56(1):110-116. doi: 10.1093/mmy/myx014.

PMID:
28340187
15.

Anti-Dermatophyte and Anti-Malassezia Activity of Extracts Rich in Polymeric Flavan-3-ols Obtained from Vitis vinifera Seeds.

Simonetti G, D'Auria FD, Mulinacci N, Innocenti M, Antonacci D, Angiolella L, Santamaria AR, Valletta A, Donati L, Pasqua G.

Phytother Res. 2017 Jan;31(1):124-131. doi: 10.1002/ptr.5739. Epub 2016 Oct 13.

PMID:
27739110
16.

Chemical Composition and Bio-efficacy of Essential Oils from Italian Aromatic Plants: Mentha suaveolens, Coridothymus capitatus, Origanum hirtum and Rosmarinus officinalis.

Spagnoletti A, Guerrinia A, Tacchini M, Vinciguerra V, Leone C, Maresca I, Simonetti G, Sacchetti G, Angiolella L.

Nat Prod Commun. 2016 Oct;11(10):1517-1520.

PMID:
30549611
17.

Cell wall composition and biofilm formation of azoles-susceptible and -resistant Candida glabrata strains.

Vitali A, Vavala E, Marzano V, Leone C, Castagnola M, Iavarone F, Angiolella L.

J Chemother. 2017 Jun;29(3):164-172. doi: 10.1080/1120009X.2016.1199507. Epub 2016 Jul 20.

PMID:
27439026
18.

Antimicrobial activity, synergism and inhibition of germ tube formation by Crocus sativus-derived compounds against Candida spp.

Carradori S, Chimenti P, Fazzari M, Granese A, Angiolella L.

J Enzyme Inhib Med Chem. 2016;31(sup2):189-193. Epub 2016 May 10.

PMID:
27160150
19.

Properties and limits of some essential oils: chemical characterisation, antimicrobial activity, interaction with antibiotics and cytotoxicity.

Scazzocchio F, Garzoli S, Conti C, Leone C, Renaioli C, Pepi F, Angiolella L.

Nat Prod Res. 2016 Sep;30(17):1909-18. doi: 10.1080/14786419.2015.1086346. Epub 2015 Sep 23.

PMID:
26395247
20.

Multidisciplinary Approach to Determine the Optimal Time and Period for Extracting the Essential Oil from Mentha suaveolens Ehrh.

Garzoli S, Pirolli A, Vavala E, Di Sotto A, Sartorelli G, Božović M, Angiolella L, Mazzanti G, Pepi F, Ragno R.

Molecules. 2015 May 26;20(6):9640-55. doi: 10.3390/molecules20069640.

21.

Antibacterial activity of essential oils mixture against PSA.

Vavala E, Passariello C, Pepi F, Colone M, Garzoli S, Ragno R, Pirolli A, Stringaro A, Angiolella L.

Nat Prod Res. 2016;30(4):412-8. doi: 10.1080/14786419.2015.1022543. Epub 2015 Mar 18.

PMID:
25782920
22.

Effects of Mentha suaveolens essential oil on Chlamydia trachomatis.

Sessa R, Di Pietro M, De Santis F, Filardo S, Ragno R, Angiolella L.

Biomed Res Int. 2015;2015:508071. doi: 10.1155/2015/508071. Epub 2015 Jan 22.

23.

Glutathione metabolism in Candida albicans resistant strains to fluconazole and micafungin.

Maras B, Angiolella L, Mignogna G, Vavala E, Macone A, Colone M, Pitari G, Stringaro A, Dupré S, Palamara AT.

PLoS One. 2014 Jun 4;9(6):e98387. doi: 10.1371/journal.pone.0098387. eCollection 2014.

24.

Effects of Mentha suaveolens Essential Oil Alone or in Combination with Other Drugs in Candida albicans.

Stringaro A, Vavala E, Colone M, Pepi F, Mignogna G, Garzoli S, Cecchetti S, Ragno R, Angiolella L.

Evid Based Complement Alternat Med. 2014;2014:125904. doi: 10.1155/2014/125904. Epub 2014 Feb 27.

25.

In vitro inhibition of herpes simplex virus type 1 replication by Mentha suaveolens essential oil and its main component piperitenone oxide.

Civitelli L, Panella S, Marcocci ME, De Petris A, Garzoli S, Pepi F, Vavala E, Ragno R, Nencioni L, Palamara AT, Angiolella L.

Phytomedicine. 2014 May 15;21(6):857-65. doi: 10.1016/j.phymed.2014.01.013. Epub 2014 Mar 11.

PMID:
24629600
26.

The cell wall protein Rhd3/Pga29 is over-expressed in Candida albicans upon micafungin treatment.

Vavala E, Mignogna G, Spano F, Stringaro A, Colone M, Sanguinetti M, Maras B, Angiolella L.

J Chemother. 2013 Dec;25(6):332-40. doi: 10.1179/1973947813Y.0000000091. Epub 2013 Dec 6.

PMID:
24090751
27.

Italian population-based values of EQ-5D health states.

Scalone L, Cortesi PA, Ciampichini R, Belisari A, D'Angiolella LS, Cesana G, Mantovani LG.

Value Health. 2013 Jul-Aug;16(5):814-22. doi: 10.1016/j.jval.2013.04.008. Epub 2013 Jun 19.

28.

Characterization of biofilms in drug-sensitive and drug-resistant strains of Candida albicans.

Vavala E, Colone M, Passariello C, Celestino I, Toccacieli L, Stringaro A, Angiolella L.

J Chemother. 2013 Apr;25(2):87-95. doi: 10.1179/1973947812Y.0000000047.

PMID:
23684356
29.

Systemic vasculitis: how little we know about their societal and economic burden.

Trieste L, Palla I, Baldini C, Talarico R, D'Angiolella L, Mosca M, Turchetti G.

Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S154-6. Epub 2012 Oct 16. Review.

PMID:
23072925
30.

Systematic literature review on economic implications and pharmacoeconomic issues of psoriatic arthritis.

Cortesi PA, Scalone L, D'Angiolella L, Belisari A, Fusco F, Olivieri I, Mantovani LG.

Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S126-31. Epub 2012 Oct 18. Review.

PMID:
23072771
31.

Beneficial effect of Mentha suaveolens essential oil in the treatment of vaginal candidiasis assessed by real-time monitoring of infection.

Pietrella D, Angiolella L, Vavala E, Rachini A, Mondello F, Ragno R, Bistoni F, Vecchiarelli A.

BMC Complement Altern Med. 2011 Feb 28;11:18. doi: 10.1186/1472-6882-11-18.

32.

Localisation of Bgl2p upon antifungal drug treatment in Candida albicans.

Angiolella L, Vitali A, Stringaro A, Mignogna G, Maras B, Bonito M, Colone M, Palamara AT, Cassone A.

Int J Antimicrob Agents. 2009 Feb;33(2):143-8. doi: 10.1016/j.ijantimicag.2008.08.021. Epub 2008 Nov 14.

PMID:
19013773
33.

Antifungal-protein production in maize (Zea mays) suspension cultures.

Perri F, Della Penna S, Rufini F, Patamia M, Bonito M, Angiolella L, Vitali A.

Biotechnol Appl Biochem. 2009 Apr;52(Pt 4):273-81. doi: 10.1042/BA20080060.

PMID:
18666889
34.

Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans.

Angiolella L, Stringaro AR, De Bernardis F, Posteraro B, Bonito M, Toccacieli L, Torosantucci A, Colone M, Sanguinetti M, Cassone A, Palamara AT.

Antimicrob Agents Chemother. 2008 Mar;52(3):927-36. doi: 10.1128/AAC.01223-07. Epub 2008 Jan 7.

35.

Glucan-associated protein modulations and ultrastructural changes of the cell wall in Candida albicans treated with micafungin, a water-soluble, lipopeptide antimycotic.

Angiolella L, Maras B, Stringaro AR, Arancia G, Mondello F, Girolamo A, Palamara AT, Cassone A.

J Chemother. 2005 Aug;17(4):409-16.

PMID:
16167521
36.

Antifungal agents. 11. N-substituted derivatives of 1-[(aryl)(4-aryl-1H-pyrrol-3-yl)methyl]-1H-imidazole: synthesis, anti-Candida activity, and QSAR studies.

Di Santo R, Tafi A, Costi R, Botta M, Artico M, Corelli F, Forte M, Caporuscio F, Angiolella L, Palamara AT.

J Med Chem. 2005 Aug 11;48(16):5140-53.

PMID:
16078834
37.

Detection of human P-glycoprotein-like molecule in azole-resistant Candida albicans from HIV+ patients.

Stringaro A, Molinari A, Calcabrini A, Arancia G, Ceddia PG, Cianfriglia M, Poloni F, Mondello F, Angiolella L, De Bernardis F, Cassone A.

Microb Drug Resist. 2002 Fall;8(3):235-44.

PMID:
12363014
38.

Identification of major glucan-associated cell wall proteins of Candida albicans and their role in fluconazole resistance.

Angiolella L, Micocci MM, D'Alessio S, Girolamo A, Maras B, Cassone A.

Antimicrob Agents Chemother. 2002 Jun;46(6):1688-94.

40.

Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics.

Angiolella L, Facchin M, Stringaro A, Maras B, Simonetti N, Cassone A.

J Infect Dis. 1996 Mar;173(3):684-90.

PMID:
8627033
41.

The activity of cilofungin on the incorporation of glucan associated proteins into hyphal cells of Candida albicans.

Angiolella L, Facchin M, Simonetti N, Cassone A.

J Chemother. 1995 Apr;7(2):83-9.

PMID:
7666125
42.
43.

Glucan synthesis and its inhibition by cilofungin in susceptible and resistant strains of Candida albicans.

Angiolella L, Bromuro C, Simonetti N, Cassone A.

J Med Vet Mycol. 1992;30(5):369-76.

PMID:
1469538
44.

The effect of antimycotics on secretory acid proteinase of Candida albicans.

Angiolella L, De Bernardis F, Bromuro C, Mondello F, Ceddia T, Cassone A.

J Chemother. 1990 Feb;2(1):55-61.

PMID:
2185347
45.

Analysis of cell wall proteins of Candida albicans.

Angiolella L, Torosantucci A, Taraborelli T, Bromuro C, Carruba G.

J Chemother. 1989 Jul;1(4 Suppl):403-6. No abstract available.

PMID:
16312460
46.

Protein synthesis and amino acid pool during yeast-mycelial transition induced by N-acetyl-D-glucosamine in Candida albicans.

Torosantucci A, Angiolella L, Filesi C, Cassone A.

J Gen Microbiol. 1984 Dec;130(12):3285-93.

PMID:
6394717
47.

31P nuclear magnetic resonance study of growth and dimorphic transition in Candida albicans.

Cassone A, Carpinelli G, Angiolella L, Maddaluno G, Podo F.

J Gen Microbiol. 1983 May;129(5):1569-75.

PMID:
6352859
48.
49.

[Induction of hyphal transformation, uptake and incorporation of N-acetyl-D-glucosamine in Candida albicans].

Mattia E, Carruba G, Angiolella L, Cassone A.

Ann Ist Super Sanita. 1982;18(3):493-6. Italian. No abstract available.

PMID:
6765081

Supplemental Content

Loading ...
Support Center